Randhawa Simrat
SEC insider (Form 3/4/5 filer). CIK 0001992260. EVP, Head of R&D at Dianthus Therapeutics, Inc. /DE/ (DNTH). 30 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in NEW YORK, NY.
Companies Randhawa Simrat has filed insider reports for
- Dianthus Therapeutics, Inc. /DE/ (DNTH): Officer, EVP, Head of R&D
Randhawa Simrat
CIK: 0001992260
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dianthus Therapeutics, Inc. /DE/
Discretionary Trading P&L
Holdings
Transaction History (30 total)
- Sep 1, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect7.2K shares at avg. $106.25$767K - Sep 1, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect7.5K shares at avg. $17.88$134K - Sep 1, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect2.6K shares at avg. $105.19$273K - Sep 1, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect13.3K shares at avg. $106.74$1.4M - Sep 1, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect6.2K shares at avg. $21.77$136K - Sep 1, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect9.4K shares at avg. $22.07$207K - Jun 1, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect6.9K shares at avg. $17.88$124K - Jun 1, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect4K shares at avg. $8.44$34K - Jun 1, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect5.4K shares at avg. $89.72$487K - Jun 1, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect4.2K shares at avg. $91.37$380K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 7,215 | $106.25 | $766,594 | Direct |
| Sep 1, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 7,500 | $17.88 | $134,100 | Direct |
| Sep 1, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 2,600 | $105.19 | $273,494 | Direct |
| Sep 1, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 13,309 | $106.74 | $1,420,603 | Direct |
| Sep 1, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 6,249 | $21.77 | $136,041 | Direct |
| Sep 1, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 9,375 | $22.07 | $206,906 | Direct |
| Jun 1, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 6,908 | $17.88 | $123,515 | Direct |
| Jun 1, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 3,998 | $8.44 | $33,743 | Direct |
| Jun 1, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 5,428 | $89.72 | $487,000 | Direct |
| Jun 1, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 4,159 | $91.37 | $380,008 | Direct |
1-10 of 30 transactions